RNASE1 and familial dilated cardiomyopathy: Although eRNA levels in DCM have not been reported so far, the observed higher RNASE1 levels in DCM patients might be considered protective, since RNASE1 supplementation [53] or induction [54] exerts positive effects on the cardiovascular system by reducing cytokine release and antioxidant enzyme levels.